IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells.

about

IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells.

Item

http://www.wikidata.org/entity/Q48120081

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

IL-4 downregulates expression ...... neoplastic canine mast cells.

@en

IL-4 downregulates expression ...... neoplastic canine mast cells.

@nl

type

Item

label

IL-4 downregulates expression ...... neoplastic canine mast cells.

@en

IL-4 downregulates expression ...... neoplastic canine mast cells.

@nl

prefLabel

IL-4 downregulates expression ...... neoplastic canine mast cells.

@en

IL-4 downregulates expression ...... neoplastic canine mast cells.

@nl

P1476

IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells

@en

P2093

A Pirker

http://www.w3.org/2001/XMLSchema#string

K Bauer

http://www.w3.org/2001/XMLSchema#string

M Reifinger

http://www.w3.org/2001/XMLSchema#string

S Cerny-Reiterer

http://www.w3.org/2001/XMLSchema#string

P2860

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Phase I evaluation of STA-1474, a prodrug of the novel HSP90 inhibitor ganetespib, in dogs with spontaneous cancer

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

CD30 in normal and neoplastic cells.

Comparative immunohistochemical characterization of canine seminomas and Sertoli cell tumors.

Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor.

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

Diagnostic criteria and classification of mastocytosis: a consensus proposal.

The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

P304

1240-1256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/VCO.12260

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27507155

http://www.w3.org/2001/XMLSchema#string

P921

mast cells

P932

5798577

http://www.w3.org/2001/XMLSchema#string